TY - JOUR
T1 - A two-stage approach for joint modeling of longitudinal measurements and competing risks data
AU - Mehdizadeh, P.
AU - Baghfalaki, Taban
AU - Esmailian, M.
AU - Ganjali, M.
N1 - Publisher Copyright:
© 2021 Taylor & Francis Group, LLC.
PY - 2021
Y1 - 2021
N2 - Joint modeling of longitudinal measurements and time-to-event data is used in many practical studies of medical sciences. Most of the time, particularly in clinical studies and health inquiry, there are more than one event and they compete for failing an individual. In this situation, assessing the competing risk failure time is important. In most cases, implementation of joint modeling involves complex calculations. Therefore, we propose a two-stage method for joint modeling of longitudinal measurements and competing risks (JMLC) data based on the full likelihood approach via the conditional EM (CEM) algorithm. In the first stage, a linear mixed effect model is used to estimate the parameters of the longitudinal sub-model. In the second stage, we consider a cause-specific sub-model to construct competing risks data and describe an approximation for the joint log-likelihood that uses the estimated parameters of the first stage. We express the results of a simulation study and perform this method on the “standard and new anti-epileptic drugs” trial to check the effect of drug assaying on the treatment effects of lamotrigine and carbamazepine through treatment failure.
AB - Joint modeling of longitudinal measurements and time-to-event data is used in many practical studies of medical sciences. Most of the time, particularly in clinical studies and health inquiry, there are more than one event and they compete for failing an individual. In this situation, assessing the competing risk failure time is important. In most cases, implementation of joint modeling involves complex calculations. Therefore, we propose a two-stage method for joint modeling of longitudinal measurements and competing risks (JMLC) data based on the full likelihood approach via the conditional EM (CEM) algorithm. In the first stage, a linear mixed effect model is used to estimate the parameters of the longitudinal sub-model. In the second stage, we consider a cause-specific sub-model to construct competing risks data and describe an approximation for the joint log-likelihood that uses the estimated parameters of the first stage. We express the results of a simulation study and perform this method on the “standard and new anti-epileptic drugs” trial to check the effect of drug assaying on the treatment effects of lamotrigine and carbamazepine through treatment failure.
KW - competing risks data
KW - joint modeling
KW - longitudinal measurements
KW - The conditional expected maximization algorithm
KW - two-stage approach
UR - https://www.scopus.com/pages/publications/85105192972
U2 - 10.1080/10543406.2021.1918142
DO - 10.1080/10543406.2021.1918142
M3 - Article
C2 - 33905295
AN - SCOPUS:85105192972
SN - 1054-3406
VL - 31
SP - 448
EP - 468
JO - Journal of Biopharmaceutical Statistics
JF - Journal of Biopharmaceutical Statistics
IS - 4
ER -